Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › About Us › Our Staff › Andrew P. Han

Andrew P. Han

Editor
Phone Number
+1-212-651-5640
Email
[email protected]

Andrew Han covers breaking news for GenomeWeb. He tracks companies in the sequencing and diagnostic markets.

Articles Authored by Andrew P. Han

Sep 21, 2020

Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider

Premium

Illumina thinks the next-generation sequencing cancer testing market will grow to $75 billion over the next 15 years, driven by screening.

Aug 17, 2020

Bionano Genomics Expecting Clinical Validation Studies to Drive Platform Adoption

Premium

The firm is hoping that researcher-generated data will soon be published in peer-reviewed papers, while it weathers the COVID-19 pandemic.

Aug 07, 2020

Illumina Sees Expanding Sequencing Market in COVID-19 Response, Despite Short-Term Woes

Premium

The sequencing firm said infectious disease research, diagnostics, screening, and surveillance could all increase demand for its NGS products.

Aug 05, 2020

Fulgent Genetics Touts Returns on COVID-19 Testing Investment

Premium

Company officials credited investments in information technology, as well as R&D for RT-PCR-based tests, with driving up the firm's billable testing numbers.

Jun 26, 2020

Iowa Startup FBB Biomed Pursues RNA Blood Test to Predict COVID-19 Disease Severity

Premium

FBB Biomed, cofounded by a diagnostics industry veteran, is attempting to develop a blood RNA test to predict COVID-19 disease severity.

Jun 11, 2020

Avida Biomed Developing Hybridization-Based Methylation Sequencing Panels for Cancer Dx

Premium

The firm touts a new hybridization probe design, which it says will enable small, focused panels that reduce sequencing costs and assay time.

Jun 09, 2020

Judge Allows Whistleblower Suit Against Myriad Genetics to Proceed

Premium

In January a federal court unsealed a False Claims Act suit from an industry insider that alleges a Myriad subsidiary engaged in a fraudulent kickback scheme.

May 29, 2020

Fry Laboratories Plans COVID-19 NGS Diagnostic Kit Offering

Premium

The infectious disease testing firm has developed a sequencing-based coronavirus assay, which it plans to commercialize through its sister firm BioID Genomics. 

May 13, 2020

Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19

Premium

The diagnostics firm is conducting a 1,000-person study to find T cell profiles associated with the immune response to COVID-19 and recovery from the disease.

Mar 11, 2020

Fulgent Genetics Developing PCR, NGS Coronavirus Diagnostic Tests

Premium

Fulgent and its China-based joint venture  are  working on a clinical NGS-based  test that  it says will have better  sensitivity than RT-PCR-based kits.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.